1-4 of 4
George Goshua
Close
Sort by
Journal Articles

Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia

Daniel Wang, Satoko Ito, Christina Waldron, Ayesha Butt, Ellen Zhang, Harlan M. Krumholz, Hanny Al-Samkari, George Goshua
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2835–2845.
https://doi.org/10.1182/bloodadvances.2024012589
Published: 2024
Includes: Supplemental data
Journal Articles

Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura

Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A. Tormey, Harlan M. Krumholz, Adam Cuker, George Goshua
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2279–2289.
https://doi.org/10.1182/bloodadvances.2024012608
Published: 2024
Includes: Supplemental data
Journal Articles

A neutrophil activation signature predicts critical illness and mortality in COVID-19

Clinical Trials & Observations
Matthew L. Meizlish, Alexander B. Pine, Jason D. Bishai, George Goshua, Emily R. Nadelmann, Michael Simonov, C-Hong Chang, Hanming Zhang, Marcus Shallow, Parveen Bahel, Kent Owusu, Yu Yamamoto, Tanima Arora, Deepak S. Atri, Amisha Patel, Rana Gbyli, Jennifer Kwan, Christine H. Won, Charles Dela Cruz, Christina Price, Jonathan Koff, Brett A. King, Henry M. Rinder, F. Perry Wilson, John Hwa, Stephanie Halene, William Damsky, David van Dijk, Alfred I. Lee, Hyung J. Chun
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1164–1177.
https://doi.org/10.1182/bloodadvances.2020003568
Published: 2021
Includes: Supplemental data
Journal Articles

Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura

George Goshua, Amit Gokhale, Jeanne E. Hendrickson, Christopher Tormey, Alfred Ian Lee
Journal: Blood Advances
Blood Adv (2020) 4 (3): 539–545.
https://doi.org/10.1182/bloodadvances.2019000827
Published: 2020
Includes: Supplemental data